Amlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan

苯磺酸氨氯地平/阿托伐他汀钙/缬沙坦

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAmlodipine Besylate/Atorvastatin Calcium Hydrate/Valsartan
Drug Alias Name苯磺酸氨氯地平/缬沙坦/阿托伐他汀钙Amlodipine/atorvastatin/valsartanAtorvastatin/amlodipine/valsartanValsartan/atorvastatin/amlodipineCJ 30061
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelHMG-CoA reductase
Therapy Area/IndicationsHyperlipidemiasHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes ValsartanAmlodipine BesylateAtorvastatin Calcium Hydrate
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHK inno.N Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHK inno.N Corporation
Active IndicationsN/A
Inactive IndicationsHyperlipidemiasHypertension

Other Information

ATC CodeN/A
Related LinksN/A